Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
Edition
European
US
General Healthcare
Filter
Journals
Congress reviews
Abstracts
Articles
Interviews
Podcasts
Videos & Webinars
News
Infographics
Society updates
Submit A Paper
Darolutamide Reduces Metastasis Risk in Prostate Cancer: ESMO 2026
October 2026
Adding darolutamide to hormone therapy and radiotherapy improved metastasis-free survival in high-risk prostate cancer, according to research presented at ESMO 2026.
Read more
27 Oct 2026
Darolutamide Reduces Metastasis Risk in Prostate Cancer: ESMO 2026
Adding darolutamide to hormone therapy and radiotherapy improved metastasis-free survival in high-risk prostate cancer, according to research presented at ESMO 2026.
25 Oct 2026
Targeted Combination Improves Lung Cancer Survival: ESMO 2026
Osimertinib plus savolitinib cut death risk by 32% versus chemotherapy in selected patients with resistant lung cancer, according to new trial results presented at ESMO 2026.
24 Oct 2026
New Personalised mRNA Therapy Improves Melanoma Outcomes: ESMO 2026
Intismeran improved melanoma outcomes and reduced reoccurrence by over 40%, but leaked trial data fell short of investor expectations, hitting Moderna and Merck shares.
7 Sep 2026
Smoking Linked to Greater Loneliness in Adults: ERS 2026
Smoking is associated with greater loneliness and increasing loneliness over time among older adults, new research suggests.
28 May 2026
79th World Health Assembly: Obesity Drives Disability in Europe
A WHO expert has called for early prevention strategies to address obesity as a global public health crisis, speaking with EMJ during the 79th World Health Assembly.
26 May 2026
79th World Health Assembly: Severe Gaps in National Mortality Data
There are severe gaps in national mortality monitoring, with only 73 Member States able to produce regular death counts, a data expert told EMJ at the 79th World Health Assembly.
26 May 2026
79th World Health Assembly: HIV Epidemic – Barriers and Breakthroughs
Amid promising developments in prevention and diagnostics, barriers persist for vulnerable groups, a WHO expert told EMJ at the 79th World Health Assembly.
22 May 2026
79th World Health Assembly: Maternal Deaths Set to Miss 2030 Target
The global maternal mortality ratio is around seven times lower than the rate needed to reach the SDG target, EMJ heard at the 79th World Health Assembly.
Loading posts...
1
2
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View